USANA Health Sciences, Inc. Stock

$30.35

0.91% day before yesterday

NYSE, Jul 18, 10:10 pm CET

ISIN

US90328M1071

Symbol

USNA

Reports

Quarter | Annual

Index

NYSE Composite, S&P SmallCap 600

Sector

Consumer goods

Industry

Household/personal hygiene

Overview Dividends Analysts Charts News Strategies

USANA Health Sciences, Inc. Stock price

$30.35

-60.85 66.72% 5Y

NYSE, Closing price Fri, Jul 18 2025

-0.28 0.91%

ISIN

US90328M1071

Symbol

USNA

Reports

Quarter | Annual

Index

NYSE Composite, S&P SmallCap 600

Sector

Consumer goods

Industry

Household/personal hygiene

Key metrics

Basic

Market capitalization

$565.2m

Enterprise Value

$408.6m

Net debt

positive

Cash

$179.6m

Shares outstanding

18.8m

Valuation (TTM | estimate)

P/E

16.6 | 11.4

P/S

0.6 | 0.6

EV/Sales

0.5 | 0.4

EV/FCF

negative

P/B

1.1

Financial Health

Equity Ratio

71.1%

Return on Equity

7.9%

ROCE

9.4%

ROIC

6.7%

Debt/Equity

0.0

Financials (TTM | estimate)

Revenue

$876.2m | $965.9m

EBITDA

$77.0m | $113.9m

EBIT

$57.3m | $79.7m

Net Income

$34.9m | $50.0m

Free Cash Flow

$-154.2m

Growth (TTM | estimate)

Revenue

-2.7% | 13.0%

EBITDA

-25.5% | 40.9%

EBIT

-36.9% | 20.1%

Net Income

-43.6% | 19.0%

Free Cash Flow

-357.3%

EPS

$1.8

FCF per Share

$-8.2

Short interest

9.6%

Employees

Rev per Employee

$500.0k

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Get Started for Free Today

USANA Health Sciences, Inc. Stock Analysis

Unlock Scores for Free

??

6 Analysts have issued a USANA Health Sciences, Inc. forecast:

3x Hold

50%

3x Sell

50%

More details on Analyst Estimates Including Price Targets

6 Analysts have issued a USANA Health Sciences, Inc. forecast:

Hold

50%

Sell

50%

Analyst Estimates with Stock Price Targets

Financial data from USANA Health Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	876 876	3% 3% 100%
- Direct Costs	171 171	0% 0% 19%
Gross Profit	706 706	3% 3% 81%
- Selling and Administrative Expenses	648 648	2% 2% 74%
- Research and Development Expense	- -	- -
EBITDA	77 77	26% 26% 9%
- Depreciation and Amortization	20 20	57% 57% 2%
EBIT (Operating Income) EBIT	57 57	37% 37% 7%
Net Profit	35 35	44% 44% 4%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

USANA Health Sciences, Inc. Stock News

Positive

Seeking Alpha

●

16 days ago

USANA Health Sciences: Premium Formulation, Discounted Valuation

USANA Health Sciences' pivot from MLM to omnichannel, highlighted by the Hiya Health acquisition, marks a strategic inflection point for renewed growth and relevance. The company's scientific credibility, strong balance sheet, and global reach position it well, despite recent revenue declines and heavy China exposure. Valuation is attractive at 12× forward earnings and 5× EBITDA, with catalysts...

Neutral

Business Wire

●

18 days ago

USANA Schedules Second Quarter 2025 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2025 results will be released after the close of market on Tuesday, July 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/E...

Neutral

PRNewsWire

●

18 days ago

USANA Executive Chairman Kevin Guest Invites All to Discover Freedom in July

SALT LAKE CITY , July 2, 2025 /PRNewswire/ -- With freedom as a universal desire being celebrated this month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals and families to celebrate freedom on a personal level for self-care. Research reveals countless global celebrations honoring freedom—from America's Independence Day on July 4 to the unifying ...

More USANA Health Sciences, Inc. News

Company Profile

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, and Sense-beautiful science. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group. The Optimizers Nutritionals category consists of targeted supplements that support cardiovascular health, skeletal and structural health, and digestive health. The Foods Nutritionals category includes low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition. The Sense-beautiful science includes premium, science-based, personal care products that support healthy skin and hair by providing topical nourishment, moisturization, and protection. The firm's brand include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Head office	United States
CEO	Jim Brown
Employees	1,700
Founded	1992
Website	www.usana.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now